Shanghai Shen Lian Biomedical Corporation (688098.SS)
CNY 5.78
(-1.03%)
CNY 5.78
(-1.03%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 31.51 Million CNY | -48.42% |
| 2022 | 61.1 Million CNY | -44.55% |
| 2021 | 110.2 Million CNY | -14.91% |
| 2020 | 129.51 Million CNY | 66.14% |
| 2019 | 77.95 Million CNY | -10.99% |
| 2018 | 87.58 Million CNY | -11.25% |
| 2017 | 98.67 Million CNY | 34.31% |
| 2016 | 73.47 Million CNY | -3.13% |
| 2015 | 75.84 Million CNY | 24.05% |
| 2014 | 61.14 Million CNY | 46.19% |
| 2013 | 41.82 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -2.2 Million CNY | 60.59% |
| 2024 Q3 | 20.38 Million CNY | 163.11% |
| 2024 Q2 | -32.29 Million CNY | -1362.02% |
| 2023 Q3 | 27.19 Million CNY | 558.13% |
| 2023 Q4 | -5.6 Million CNY | -120.61% |
| 2023 FY | 31.51 Million CNY | -48.42% |
| 2023 Q1 | 15.86 Million CNY | 239.43% |
| 2023 Q2 | -5.93 Million CNY | -137.41% |
| 2022 Q3 | 49.08 Million CNY | 7656.18% |
| 2022 Q1 | 23.92 Million CNY | 30.68% |
| 2022 FY | 61.1 Million CNY | -44.55% |
| 2022 Q4 | -11.38 Million CNY | -123.19% |
| 2022 Q2 | -649.54 Thousand CNY | -102.71% |
| 2021 FY | 110.2 Million CNY | -14.91% |
| 2021 Q4 | 18.31 Million CNY | -61.43% |
| 2021 Q1 | 28.38 Million CNY | 458.68% |
| 2021 Q2 | 16.03 Million CNY | -43.5% |
| 2021 Q3 | 47.47 Million CNY | 196.0% |
| 2020 Q4 | -7.91 Million CNY | -110.32% |
| 2020 FY | 129.51 Million CNY | 66.14% |
| 2020 Q3 | 76.67 Million CNY | 462.86% |
| 2020 Q2 | 13.62 Million CNY | -71.09% |
| 2020 Q1 | 47.12 Million CNY | 5610.74% |
| 2019 Q1 | 35.09 Million CNY | 487.94% |
| 2019 Q4 | 825.26 Thousand CNY | -97.84% |
| 2019 Q2 | 3.87 Million CNY | -88.97% |
| 2019 Q3 | 38.16 Million CNY | 885.87% |
| 2019 FY | 77.95 Million CNY | -10.99% |
| 2018 Q4 | 5.96 Million CNY | 0.0% |
| 2018 FY | 87.58 Million CNY | -11.25% |
| 2018 Q1 | 40.9 Million CNY | 0.0% |
| 2017 Q2 | 27.19 Million CNY | 0.0% |
| 2017 Q1 | 27.19 Million CNY | 55.45% |
| 2017 FY | 98.67 Million CNY | 34.31% |
| 2016 Q1 | 19.24 Million CNY | 0.0% |
| 2016 Q3 | 17.49 Million CNY | -9.1% |
| 2016 Q2 | 19.24 Million CNY | 0.0% |
| 2016 Q4 | 17.49 Million CNY | 0.0% |
| 2016 FY | 73.47 Million CNY | -3.13% |
| 2015 FY | 75.84 Million CNY | 24.05% |
| 2014 FY | 61.14 Million CNY | 46.19% |
| 2013 FY | 41.82 Million CNY | 0.0% |